GlassScriptPhysician profile
Bradley Steven Soder
NPI 1740219872
$5,045.16
in general payments reported to CMS, 2019-2025
32 companies · $1,940 in 2025
The $1,940 reported for 2025 was more than what 75% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $98.58 · 2022: $257 · 2023: $923 · 2024: $1,389 · 2025: $1,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,178 · Education: $73.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,178.38 |
| Education | $73.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,125.11 | 2019-2025 | Rinvoq, Skyrizi |
| E.R. Squibb & Sons, L.L.C. | $446.97 | 2022-2025 | Sotyktu |
| Janssen Biotech, INC. | $390.53 | 2019-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $377.52 | 2019-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $324.64 | 2022-2025 | Taltz, Ebglyss |
| Pfizer INC. | $245.87 | 2019-2025 | |
| Leo Pharma INC. | $244.99 | 2019-2025 | Adbry, Anzupgo, Spevigo |
| Genzyme Corporation | $227.39 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $216.48 | 2022-2025 | |
| Arcutis Biotherapeutics, INC. | $151.45 | 2023-2025 | Zoryve |
| Incyte Corporation | $144.69 | 2023-2025 | Opzelura |
| Journey Medical Corporation | $125.95 | 2023 | |
| Dermavant Sciences, INC. | $120.60 | 2023-2024 | Vtama |
| Ucb, INC. | $119.23 | 2022-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $116.95 | 2022-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $88.79 | 2019-2025 | Nemluvio, Aklief |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $64.49 | 2019-2023 | Arazlo |
| Organon LLC | $63.88 | 2025 | Vtama |
| Celgene Corporation | $55.56 | 2019 | |
| Botanix Sb INC | $54.63 | 2025 | Sofdra |
| Almirall LLC | $47.76 | 2019-2020 | |
| Genentech USA, INC. | $46.57 | 2019-2020 | |
| Aclaris Therapeutics, INC. | $40.54 | 2019 | |
| Mayne Pharma Commercial LLC | $38.51 | 2025 | |
| Biofrontera INC. | $30.57 | 2019-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Vyne Pharmaceuticals INC. | $27.29 | 2020 | |
| Verrica Pharmaceuticals INC. | $20.84 | 2025 | Ycanth |
| Epi Health, LLC | $20.74 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.73 | 2025 | Spevigo |
| Promius Pharma LLC | $17.49 | 2019 | |
| Novum Pharma, LLC | $16.82 | 2019 | |
| Dermira, INC. | $13.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Soder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.